The article below provides an evidence-based rationale for extending the duration of endocrine therapy in patients with ductal carcinoma in situ (DCIS) beyond the traditional 5-year mark. Findings ...
Risk-Reducing Bilateral Salpingo-Oophorectomy for Ovarian Cancer: A Review and Clinical Guide for Hereditary Predisposition Genes Recent epidemiologic data show an increasing incidence of breast ...